By using a mouse model of established colitis-driven intestinal fibrosis, we have recently shown that oral administration of Smad7 AS to colitic mice attenuated colitis thus limiting the degree of intestinal fibrosis (Izzo et al., 2018). The gene discussed is SMAD7; the disease is colitis.